Correlation between antiretroviral resistance mutations, biological parameters, and clinical evolution in zidovudine-treated patients infected with human immunodeficiency virus type 1

This publication has 22 references indexed in Scilit:

• The prognostic significance of serum viral load, codon 215 reverse transcriptase mutation and CD4+ T cells on progression of HIV disease in a double-blind study of thymopentin
  AIDS, 1996
• Clinical Significance of Drug Resistance in Human Immunodeficiency Virus
  Clinical Infectious Diseases, 1995
• Prevalence and Clinical Significance of Zidovudine Resistance Mutations in Human Immunodeficiency Virus Isolated from Patients after Long-Term Zidovudine Treatment
  The Journal of Infectious Diseases, 1995
• Clinical correlates of in vitro HIV-1 resistance to zidovudine. Results of the Multicentre Canadian AZT Trial
  AIDS, 1993
• Ordered Appearance of Zidovudine Resistance Mutations during Treatment of 18 Human Immunodeficiency Virus-Positive Subjects
  The Journal of Infectious Diseases, 1992
• HIV-1 sensitivity to zidovudine and clinical outcome in children
  The Lancet, 1992
• Zidovudine resistance predicted by direct detection of mutations in DNA from HIV-infected lymphocytes
  AIDS, 1991
• Zidovudine sensitivity of human immunodeficiency viruses from high-risk, symptom-free individuals during therapy
  The Lancet, 1990
• Multiple Mutations in HIV-1 Reverse Transcriptase Confer High-Level Resistance to Zidovudine (AZT)
  Science, 1989
• The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
  New England Journal of Medicine, 1987